Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Enpatoran, a Toll-like receptor (TLR) 7/8 inhibitor, showed modest but non-significant improvement in disease activity for moderate-to-severe systemic lupus erythematosus (SLE) patients in a phase 2 trial published this week. ... Read More
Continuous Coverage
There is a specific kind of silence that exists only in deep, limestone caverns—a heavy, damp stillness that…
Spotify is rolling out a new “Music Era” feature this week, utilizing advanced machine learning to categorize users’…
The recent podcast discussion “In Covid’s Wake,” featuring political scientists Frances Lee and Rick Pildes, examines how political…
Moving iMage Technologies (MIT) reported $3.39 million in Q3 revenue, navigating a seasonally gradual period through increased cinema…
The CIF-SS Division 1 baseball playoffs kicked off Tuesday with high-stakes matchups reshaping the postseason landscape, as Torrance’s…
NASA’s Psyche spacecraft, launched in 2023, just executed a gravity-assist flyby of Mars this week, using the red…
Global Affairs
A woman who wrote a children’s book about grief was sentenced to life in prison for poisoning her…
Markets And Money
Volkswagen Group (ETR: VOW3) has launched the electric Cupra Raval in the Czech Republic, targeting the entry-level EV…
Digital Culture
Leaked retail emails have prematurely exposed GTA 6 preorder timelines and pricing details approximately 189 days before the…
Science And Wellbeing
New Zealand’s Pharmac, the government agency that determines which medicines are publicly funded, has provisionally approved Wegovy (semaglutide…
Screen And Sound
Pixar’s *Toy Story 5*—starring Tom Hanks as Woody—is breaking franchise tradition by introducing a new human character, a…
Fixtures And Form
Real Madrid CF has officially regained possession of the Sky Bar at the Santiago Bernabéu following a court-authorized…
